NDC 51662-1220
DOPAMINE HCI
Dopamine Hci
DOPAMINE HCI is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Dopamine Hydrochloride.
| Product ID | 51662-1220_74205252-394a-57fa-e053-2991aa0aee4d |
| NDC | 51662-1220 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DOPAMINE HCI |
| Generic Name | Dopamine Hci |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-08-23 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018132 |
| Labeler Name | HF Acquisition Co. LLC, DBA Health First |
| Substance Name | DOPAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 40 mg/mL |
| Pharm Classes | Catecholamine [EPC],Catecholamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |